Preferred Label : Calcinosis Cutis;
MeSH definition : Pathological deposition of calcium in the skin and subcutaneous tissue. Excessive
calcification of the skin may be associated with underlying diseases that cause tissue
damage (e.g., EHLERS-DANLOS SYNDROME; PSEUDOXANTHOMA ELASTICUM; ROTHMUND-THOMSON SYNDROME;
and WERNER SYNDROME) or that cause abnormal calcium and phosphate metabolism (e.g.,
CALCIPHYLAXIS; CHRONIC KIDNEY FAILURE; HYPERPARATHYROIDISM; and SARCOIDOSIS).; Pathological deposition of calcium in the skin and subcutaneous tissue. Excessive
calcification of the skin may be associated with underlying diseases that cause tissue
damage (e.g. EHLERS-DANLOS SYNDROME; PSEUDOXANTHOMA ELASTICUM; ROTHMUND-THOMSON SYNDROME;
and WERNER SYNDROME) or that cause abnormal calcium and phosphate metabolism (e.g.,
CALCIPHYLAXIS; CHRONIC KIDNEY FAILURE; HYPERPARATHYROIDISM; and SARCOIDOSIS).;
MeSH synonym : Cutaneous Calcification; Calcification, Cutaneous; Cutaneous Calcifications;
MeSH hyponym : Calcinosis Cutis, Idiopathic; Calcinosis Cutis, Dystrophic; Calcinosis Cutis, Metastatic; Calcinosis Cutis, Iatrogenic;
Origin ID : D000092182;
UMLS CUI : C0006664;
Allowable qualifiers
- Currated CISMeF NLP mapping
- Record concept(s)
- See also inter- (CISMeF)
- Semantic type(s)
- UMLS correspondences (same concept)
Pathological deposition of calcium in the skin and subcutaneous tissue. Excessive
calcification of the skin may be associated with underlying diseases that cause tissue
damage (e.g., EHLERS-DANLOS SYNDROME; PSEUDOXANTHOMA ELASTICUM; ROTHMUND-THOMSON SYNDROME;
and WERNER SYNDROME) or that cause abnormal calcium and phosphate metabolism (e.g.,
CALCIPHYLAXIS; CHRONIC KIDNEY FAILURE; HYPERPARATHYROIDISM; and SARCOIDOSIS).
Pathological deposition of calcium in the skin and subcutaneous tissue. Excessive
calcification of the skin may be associated with underlying diseases that cause tissue
damage (e.g. EHLERS-DANLOS SYNDROME; PSEUDOXANTHOMA ELASTICUM; ROTHMUND-THOMSON SYNDROME;
and WERNER SYNDROME) or that cause abnormal calcium and phosphate metabolism (e.g.,
CALCIPHYLAXIS; CHRONIC KIDNEY FAILURE; HYPERPARATHYROIDISM; and SARCOIDOSIS).
